What is AVP-923 (DM/Q)?

Category: Others


A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy and to Determine the Pharmacokinetics of Two Doses of AVP-923 (Dextromethorphan/Quinidine) in the Treatment of Pseudobulbar Affect (PBA) in Patients With Amyotrophic Lateral Sclerosis and Multiple Sclerosis

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 1
None 0

Commonly reported side effects and conditions associated with AVP-923 (DM/Q)

Side effect Patients
Headaches 1

Why patients stopped taking AVP-923 (DM/Q)

Multiple reasons could be selected

Reason Patients
Side effects too severe 1
See 1 patient who's stopped using AVP-923 (DM/Q)


Stopped using AVP-923 (DM/Q)

Duration Patients
1 - 6 months 1
Adherence Evaluations
Always 1
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 1
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 1
$25-49 0
< $25 0
Not specified 0
Last updated:

1 patient evaluation for AVP-923 (DM/Q)

Feb 17, 2010 (Started Mar 21, 2006)

  • Effectiveness
    Major (for emotional lability)
  • Side effects
    Mild (headaches)
  • Adherence
  • Burden
    Not at all hard to take
Dosage: 60 mg Daily
Cost: $50-99 monthly
Side effects: headaches

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for AVP-923 (DM/Q)